Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04475640 · ClinicalTrials.gov registry record · NA
Cancer Genetic Testing in Ethnic Populations
A NA study of Malignant Solid Neoplasm and Breast Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 1,800
- Enrollment target
- 2
- Study locations
NCT04475640: Recruiting NA study of Malignant Solid Neoplasm and Breast Carcinoma, sponsored by Mayo Clinic.
NCT04475640 is a NA study of Malignant Solid Neoplasm and Breast Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,800 participants, above the 1,131-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (59% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04475640, a NA study of Malignant Solid Neoplasm and Breast Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,800 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial examines the integration of cancer genetic testing in various ethnic populations. Studying individuals and families at risk of cancer may help identify cancer genes and other persons at risk. The information from this study may provide an opportunity for cancer risk stratification and individualized screening in these ethnic populations.
Primary Outcome
Will identify the prevalence of pathogenic germline mutations in enrolled patients within each cancer site, age (\< 60 years old versus (vs.) \>= 60 years old), and stage (early vs. advanced) via descriptive statistics.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Genetic Testing
Study Locations (2)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,800 participants |
| Start Date | 2020-01-13 |
| Est. Completion | 2026-10-15 |
| Phase | NA |
What NCT04475640 shows while recruiting
NCT04475640 is an interventional study that assigns participants to a tested intervention. Its 1,800 participants enrollment target places it among the larger protocols in the corpus, above the 1,131-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (59% higher).
The record links to 10 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Biospecimen Collection is the first listed.
NCT04475640 reports a single indexed study location in Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT04475640 about?
NCT04475640 is a clinical study titled "Cancer Genetic Testing in Ethnic Populations". This clinical trial examines the integration of cancer genetic testing in various ethnic populations. Studying individuals and families at risk of cancer may help identify cancer genes and other persons at risk. The information from this study may provide an opportunity for cancer risk stratificatio...
What is the current status of trial NCT04475640?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,800 participants. The study started on 2020-01-13. Estimated completion is 2026-10-15.
What conditions does trial NCT04475640 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Breast Carcinoma, Head and Neck Carcinoma, Malignant Female Reproductive System Neoplasm, Malignant Brain Neoplasm.
What interventions are being tested in trial NCT04475640?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Genetic Testing (OTHER).
Who is sponsoring clinical trial NCT04475640?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04475640 being conducted?
This trial has 2 study locations across Arizona, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04475640's enrollment target sits among peer trials
1,800 16th of 176 higher than 161 of 176 other Malignant Solid Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
RECRUITING · NA
-
Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
RECRUITING · NA
-
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
RECRUITING · NA
-
Community-Based Physical Activity Intervention for Underserved Cancer Survivors
RECRUITING · NA
-
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
- NCT05258656 · 1,800 participants · NA
Childhood Activities Nutrition and Development Oversight
- NCT05286931 · 1,800 participants · NA
SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI